Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01822717 · ClinicalTrials.gov registry record · NA

Nonvisual Foot Inspection for People With Visual Impairment

A NA study of Diabetes and Visual Impairment, sponsored by Case Western Reserve University.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT01822717 is a NA study of Diabetes and Visual Impairment that has completed, run by Case Western Reserve University. The registered enrollment target is 30 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01822717, a NA study of Diabetes and Visual Impairment, has completed, sponsored by Case Western Reserve University.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study was to find out whether a method of nonvisual foot inspection, using the senses of touch and smell, helps people with diabetes and visual impairment to find new foot problems when they are in early, easily-treated stages. All people in the study had regular foot inspections by podiatrists. The results include how people feel about the method, whether they actually did check their feet it, and whether the method helped them to discover foot problems themselves.

Interventions

  • BEHAVIORAL Usual Care
  • BEHAVIORAL Nonvisual foot inspection

Study Locations (1)

Ohio

  • Cleveland Foot and Ankle Institute - Cleveland

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2010-09
Est. Completion 2012-09
Phase NA

Sponsor

Case Western Reserve University

141 total trials

What the Registry Record Tells You About NCT01822717

The ClinicalTrials.gov registry entry for NCT01822717 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower). The listed sponsor is Case Western Reserve University, which has 141 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT01822717 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT01822717 about?

NCT01822717 is a clinical study titled "Nonvisual Foot Inspection for People With Visual Impairment". The purpose of this study was to find out whether a method of nonvisual foot inspection, using the senses of touch and smell, helps people with diabetes and visual impairment to find new foot problems when they are in early, easily-treated stages. All people in the study had regular foot inspections...

What is the current status of trial NCT01822717?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2010-09. Estimated completion is 2012-09.

What conditions does trial NCT01822717 study?

This clinical trial studies the following conditions: Diabetes, Visual Impairment.

What interventions are being tested in trial NCT01822717?

The interventions under investigation include: Usual Care (BEHAVIORAL), Nonvisual foot inspection (BEHAVIORAL).

Who is sponsoring clinical trial NCT01822717?

This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01822717 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.